Episona adds D2C model for male fertility test using epigenetics
Seed is a next-generation sequencing test that identifies signs of DNA methylation in sperm as the result of aging, smoking, pollution and other factors.
Epigenetics startup Episona launches male fertility test
The global market for fertility medicine is now $30-40 billion per year, but many continue to view it as a women's health problem. Episona hopes to change that, with its epigenetics-based male fertility test.
presented by
Simplify Salon & Spa Employee Management with Meevo’s Comprehensive Software
Meevo offers an all-in-one solution for managing salon and spa employees. From scheduling and time tracking to payroll and promotions, Meevo streamlines operations and supports growth.